查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1928588

非洲豬瘟病毒抗體檢測ELISA試劑盒市場（按產品類型、檢測類型、檢體類型、通路、應用和最終用戶分類），全球預測，2026-2032年

ELISA Kit for Antibody Detection Against African Swine Fever Virus Market by Product Type, Test Type, Sample Type, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年非洲豬瘟病毒抗體檢測 ELISA 試劑盒市值為 7,012 萬美元，預計到 2026 年將成長至 8,047 萬美元，複合年成長率為 6.48%，到 2032 年將達到 1.0884 億美元。

關鍵市場統計數據
基準年 2025 7012萬美元
預計年份：2026年 8047萬美元
預測年份 2032 1.0884億美元
複合年成長率 (%) 6.48%

本文清楚概述了抗體ELISA診斷為何是現代非洲豬瘟病毒檢測策略和相關人員決策架構的核心。

非洲豬瘟病毒 (ASFV) 仍然是動物衛生系統面臨的持續性挑戰，因此基於抗體的ELISA檢驗對於制定全面的檢測策略至關重要。本文將競爭性 ELISA、間接 ELISA 和夾心 ELISA 等檢測方法在實驗室工作流程中的診斷作用置於中心位置，並闡明檢測方法的選擇如何與監測目標、研究重點和疫苗項目開發相關聯。隨著應對疫情的策略從孤立的疫情應對轉向綜合監測和防範，抗體 ELISA 平台如今已與分子診斷、血清流行病學和現場檢測方法並行運作。

對近期由技術、政策和合作主導的變革如何重塑非洲豬瘟病毒抗體ELISA檢測生態系統和診斷供應鏈進行了深入分析。

過去幾年，受技術進步、政策調整和動物健康優先事項轉變的推動，非洲豬瘟病毒（ASFV）的診斷格局發生了翻天覆地的變化。高通量檢查室自動化和試劑化學的改進提高了競爭性、間接和夾心ELISA檢測的可靠性和可重複性，使檢查室能夠以更高的置信度處理更多檢體。同時，數位化整合和檢查室資訊管理系統簡化了診斷檢查室、政府監測部門和研究中心之間的資料流，提高了公共衛生應對和政策決策的靈活性。

對近期美國關稅調整對非洲豬瘟病毒抗體ELISA生態系統的採購、供應鏈策略和供應商選擇的影響進行全面檢驗

美國近期實施和調整關稅所產生的累積效應遠不止於即時的成本調整，也影響籌資策略、供應鏈韌性和供應商選擇。進口試劑和檢測試劑盒關稅的提高促使一些實驗室和政府採購機構使其供應商組合多元化，重新評估長期採購契約，並納入更嚴格的總體擁有成本分析，將物流成本、前置作業時間和本地檢驗成本納入考慮。這些變化也促使製造商和經銷商重新評估其區域定價和分銷模式，加快對本地倉庫和夥伴關係網路的投資，以減輕關稅的影響並降低政策突變帶來的風險。

基於全面細分的解讀詳細說明了測試類型、最終用戶、應用程式和分銷管道如何共同影響檢測設計、採購和部署趨勢。

對市場區隔的深入理解揭示了需求、技術要求和分銷挑戰相互交織的領域，這些交織共同塑造了產品策略。按檢測類型分類，競爭性的 ELISA、間接 ELISA 和夾心 ELISA 各自具有不同的性能特徵和工作流程影響，檢查室的偏好和臨床應用。製造商必須最佳化檢測的靈敏度、特異性和易用性，以滿足這些操作限制。按最終用戶分類，診斷檢查室、政府機構、研究機構和獸醫診所各自具有獨特的檢驗要求、通量和監管需求。尤其是在診斷檢查室內部，私營和公共部門的細分市場在採購行為和服務期望方面存在差異。按應用分類，疾病診斷、研發、監測和疫苗開發都需要專門的試劑盒功能、品質文件和支援服務。在監測領域，主動監測和被動監測的差異導致檢體處理、推廣物流和報告頻率方面的差異。根據分銷管道的不同，直銷、分銷商和線上管道決定了交貨速度和成本，而國際分銷商和國內分銷商之間的區別則影響前置作業時間、監管支援和售後服務。

區域戰略洞察：美洲、歐洲、中東和非洲以及亞太地區如何各自形成不同的ELISA診斷監管、採購和分銷要求

區域趨勢在決定非洲豬瘟病毒抗體ELISA檢測的推廣時間表、監管重點和流通結構發揮著至關重要的作用。在美洲，各國法規結構的差異以及大規模的商業豬場催生了對擴充性檢查室解決方案的強勁需求。然而，廣袤地域帶來的物流複雜性進一步凸顯了區域分銷中心和技術支援網路的重要性。因此，專注於該地區的供應商強調供應鏈的穩健性和全面的驗證方案，以滿足商業養殖場和公共衛生監測的需求。在歐洲、中東和非洲，不同的管理體制和獸醫基礎設施要求供應商採取靈活的市場進入策略。有些市場需要與政府機構密切合作進行監測項目，而有些市場則依賴私人實驗室和獸醫診所進行疫情管理。在該地區運營的供應商必須平衡監管合規性與當地檢查室能力和培訓需求。在亞太地區，密集的生產基地、跨境動物疾病的高發生率以及快速發展的檢測能力正在推動對高通量平台和照護現場ELISA試劑盒的需求。此外，跨境貿易考量和區域合作舉措正日益影響籌資策略和測試標準化工作的優先順序。

對公司和機構進行深入評估，以確定製造商、經銷商和合作夥伴關係如何透過檢驗、供應連續性和支援服務來創造競爭優勢。

非洲豬瘟病毒抗體ELISA領域的主要企業因其提供檢驗的檢測性能、可靠的供應鏈和一體化的支援服務而備受認可。提供多種ELISA檢測形式的成熟廠商透過提供全面的技術文件、交叉檢驗數據和擴充性的生產能力來滿足緊急監測需求，從而展現出競爭優勢。同時，新興創新者提供專門的檢測化學方法、簡化的使用者介面或模組化平台，以便在資源有限的環境和獸醫診所中實施。經銷商和物流合作夥伴發揮著至關重要的作用，他們確保跨多個司法管轄區的低溫運輸完整性、及時交付和監管支持，使廠商能夠覆蓋分散的檢測點。

為製造商、經銷商和相關人員提供切實可行的策略建議，以加速抗體 ELISA 檢測的普及應用，並加強檢驗、供應鏈韌性和支援服務。

產業領導者應採取多管齊下的策略，以加速非洲豬瘟病毒抗體ELISA診斷試劑盒的推廣應用，並增強營運韌性。首先，透過投資完善的檢驗和文件編制，使檢測性能符合監管要求和檢查室認證標準，從而降低公立和私立診斷檢查室的採購門檻。其次，透過在關鍵市場開展直銷，並與國內外經銷商建立策略合作夥伴關係，實現分銷網路多元化，從而降低海關風險並縮短前置作業時間。第三，拓展支援服務，包括現場和遠端培訓、與檢查室資訊系統整合以及上市後檢測性能監測，以建立與政府機構和研究機構的信任。

一項透明的混合方法調查方法詳細介紹了用於深入了解 ELISA 診斷的採用和部署的初步訪談、二次檢驗和分析框架。

本報告結合質性研究和一手調查方法，以確保得出可靠且基於證據的結論。一手資料來自對診斷檢查室主任、政府監管管理人員、獸醫和科研人員的結構化訪談，並輔以供應商巡迴推介和經銷商評估，以了解實際採購和物流方面的考量。二手分析整合了同儕審查文獻、監管指導文件和技術檢驗報告，以檢驗競爭性、間接和夾心ELISA方法的性能特徵。

總之，這份簡要總結強調了適應性檢驗、供應鏈韌性和協作部署策略對於最佳化基於 ELISA 的非洲豬瘟病毒抗體檢測的重要性。

總之，非洲豬瘟病毒（ASFV）抗體ELISA診斷在現代監測、診斷和控制體系中佔據著至關重要的地位。檢測化學技術的進步、採購趨勢的轉變以及各地區監管環境的差異，都要求製造商、經銷商和最終用戶採取適應性策略，優先考慮檢驗、供應連續性和客製化支援。按檢測類型、最終用戶、應用和通路進行細分，可以突顯產品差異化和增強服務在推動產品應用方面最為有效的領域。同時，區域差異也凸顯了製定客製化監管和物流方案的必要性。將知識轉化為實踐需要產業、政府和研究機構的共同努力，以確保檢測能夠在各種實驗室和現場環境的操作限制下提供可靠的結果。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依產品類型分類）

  • 間接ELISA試劑盒
    • IgG抗體檢測
    • 總抗體檢測
  • 阻斷與競爭性ELISA試劑盒
    • 基於單株抗體的
    • 基於多株抗體
  • 雙抗原夾心ELISA試劑盒

9. 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依檢測類型分類）

  • 競爭性ELISA
  • 間接ELISA
  • 夾心ELISA

第10章 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依檢體類型分類）

  • 血清樣本
    • 個體動物血清
    • 混合血清
  • 血漿樣本
  • 全血
  • 口腔液
  • 組織萃取物

第11章 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依通路分類）

  • 直銷
  • 經銷商
    • 國際經銷商
    • 國內經銷商
  • 線上

第12章 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依應用分類）

  • 疾病診斷
  • 調查
  • 監測
    • 主動監測
    • 被動監測
  • 疫苗研發

第13章 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依最終用戶分類）

  • 診斷實驗室
    • 私人的
    • 公共機構
  • 政府機構
  • 研究所
  • 獸醫院

14. 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依地區分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 非洲豬瘟病毒抗體檢測ELISA試劑盒市場（依國家分類）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國：非洲豬瘟病毒抗體檢測ELISA試劑盒市場

18. 中國：非洲豬瘟病毒抗體檢測ELISA試劑盒市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abcam plc
  • Adiagen, Inc.
  • Bionote, Inc.
  • Biosellal SA
  • BioStone Animal Health LLC
  • Boehringer Ingelheim Svanova
  • Cusabio Biotech Co., Ltd.
  • Gold Standard Diagnostics, Inc.
  • ID.vet Innovative Diagnostics
  • IDEXX Laboratories, Inc.
  • Indical Bioscience GmbH
  • J&G Biotech Ltd.
  • Merck KGaA
  • R&D Systems, Inc.
  • Tetracore, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-92740D85F050

The ELISA Kit for Antibody Detection Against African Swine Fever Virus Market was valued at USD 70.12 million in 2025 and is projected to grow to USD 80.47 million in 2026, with a CAGR of 6.48%, reaching USD 108.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 70.12 million
Estimated Year [2026] USD 80.47 million
Forecast Year [2032] USD 108.84 million
CAGR (%) 6.48%

Clear foundational overview emphasizing why antibody ELISA diagnostics are central to modern African Swine Fever virus detection strategies and stakeholder decision frameworks

African Swine Fever Virus (ASFV) continues to present a persistent challenge across animal health systems, and antibody-based ELISA assays have become integral to comprehensive detection strategies. This introduction frames the diagnostic role of Competitive ELISA, Indirect ELISA, and Sandwich ELISA formats within laboratory workflows and highlights how assay selection intersects with surveillance objectives, research priorities, and vaccine program development. The landscape has shifted from isolated outbreak response toward integrated surveillance and preparedness, and antibody ELISA platforms now operate alongside molecular diagnostics, seroepidemiology, and field-based testing modalities.

In practical terms, diagnostic laboratories, government agencies, research institutions, and veterinary hospitals encounter distinct operational requirements that drive procurement, validation, and deployment decisions. Diagnostic laboratories must balance throughput and specificity while government agencies focus on surveillance sensitivity and traceability. Research institutions prioritize assay flexibility for experimental designs, and veterinary hospitals emphasize rapid clinical decision support. As a result, product design, regulatory strategy, and distribution models all evolve to meet these varied end-user needs. Consequently, stakeholders must appreciate the technical nuance of assay formats and align procurement and validation pathways to local and international regulatory expectations.

Insightful analysis of the recent technological, policy and collaboration-driven transitions reshaping African Swine Fever virus antibody ELISA testing ecosystems and diagnostic supply chains

Over the last several years, the diagnostics environment for ASFV has undergone transformative shifts driven by technological advances, policy recalibration, and changing animal health priorities. High-throughput laboratory automation and improved reagent chemistries have increased the reliability and reproducibility of Competitive, Indirect, and Sandwich ELISA formats, enabling laboratories to process larger sample volumes with greater confidence. At the same time, digital integration and laboratory information management systems have streamlined data flows between diagnostic laboratories, government surveillance units, and research centers, improving the timeliness of public health responses and policy decisions.

Moreover, the industry has adapted to a more collaborative posture between public and private actors. Government agencies and research institutions now share validation protocols and reference materials more readily, which accelerates assay adoption and harmonizes performance expectations. This shift is further reinforced by increasing emphasis on One Health principles that recognize the interplay between veterinary diagnostics, epidemiology, and agricultural economics. Consequently, manufacturers and distributors are redesigning their value propositions to emphasize end-to-end service, including technical support, training, and integration with surveillance programs, rather than focusing solely on reagent supply.

Comprehensive examination of how recent United States tariff adjustments have reshaped procurement, supply chain strategies, and vendor selection across the antibody ELISA ecosystem for African Swine Fever virus

The recent imposition and recalibration of tariffs within the United States have created cumulative effects that extend beyond immediate cost adjustments to influence procurement strategies, supply chain resilience, and vendor selection. Increased duties on imported reagents and assay kits have encouraged some laboratories and government procurement bodies to diversify supplier portfolios and to re-evaluate long-term sourcing arrangements, integrating more rigorous total-cost-of-ownership analyses that factor in logistical overheads, lead times, and local validation expenses. These dynamics have also prompted manufacturers and distributors to revisit their regional pricing and distribution models, accelerating investments in local warehousing and partnership networks to mitigate tariff impacts and reduce exposure to sudden policy shifts.

As a consequence, end users increasingly demand greater transparency in pricing breakdowns and continuity guarantees, while procurement teams prioritize vendors with demonstrated regional presence or established national distribution channels. Research institutions have faced similar pressures; they now place higher value on suppliers that provide robust technical documentation and training during assay transfer processes. Transitioning from reactive adjustments to proactive supply chain design has become essential, and stakeholders who adopt adaptive procurement frameworks position themselves to maintain testing continuity despite regulatory and tariff-related turbulence.

Holistic segmentation-driven interpretation detailing how test types, end users, applications, and distribution channels collectively determine assay design, procurement and deployment dynamics

A granular understanding of market segmentation illuminates where demand, technical requirements, and distribution challenges converge to shape product strategies. Based on Test Type, Competitive ELISA, Indirect ELISA, and Sandwich ELISA offer distinct performance characteristics and workflow implications that influence laboratory preference and clinical application; manufacturers must therefore optimize assay sensitivity, specificity, and ease of use to fit those operational constraints. Based on End User, Diagnostic Laboratories, Government Agencies, Research Institutions, and Veterinary Hospitals each bring unique validation, throughput, and regulatory needs, and within Diagnostic Laboratories the private and public subsegments demonstrate divergent purchasing behaviors and service expectations. Based on Application, Disease Diagnosis, Research, Surveillance, and Vaccine Development require tailored kit features, quality documentation, and support services, and within Surveillance the split between Active Surveillance and Passive Surveillance drives differences in sample handling, outreach logistics, and reporting cadences. Based on Distribution Channel, Direct Sales, Distributors, and Online channels determine the speed and cost of delivery, while the differentiation between International Distributors and National Distributors affects lead times, regulatory assistance, and after-sales support.

This segmentation framework reveals multiple commercial levers. For example, products engineered to meet the throughput demands of public diagnostic laboratories will differ in format and documentation from kits designed for research laboratories seeking flexible assay conditions. Similarly, surveillance-focused deployments require robust supply continuity and clear chain-of-custody features, whereas veterinary hospitals prioritize rapid clinical turnaround and simplified workflows. Distribution strategy must therefore align with end-user expectations; manufacturers that refine channel approaches to provide both direct engagement and strong distributor partnerships can reduce friction and increase adoption across diverse user groups.

Strategic regional insights explaining how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape differentiated regulatory, procurement and distribution imperatives for ELISA diagnostics

Regional dynamics play a decisive role in shaping adoption timelines, regulatory priorities, and distribution architectures for ASFV antibody ELISA assays. In the Americas, varied national regulatory frameworks and large-scale commercial swine operations create a strong demand for scalable laboratory solutions, yet logistical complexity across wide geographies also heightens the importance of local distribution hubs and technical support networks. Consequently, vendors focusing on this region emphasize supply chain robustness and comprehensive validation packages to meet both commercial farm and public health surveillance needs. In Europe, Middle East & Africa, heterogeneous regulatory regimes and diverse veterinary infrastructures require adaptable go-to-market approaches; some markets demand close collaboration with government agencies for surveillance programs, while others rely on private diagnostic laboratories and veterinary clinics for outbreak management. Suppliers operating here must balance regulatory conformity with sensitivity to local laboratory capabilities and training needs. In the Asia-Pacific region, dense production hubs, a high incidence of transboundary animal disease concerns, and rapidly advancing laboratory capacity drive demand for both high-throughput platforms and point-of-care compatible ELISA kits. In addition, cross-border trade considerations and regional cooperation initiatives increasingly inform procurement strategies and the prioritization of assay standardization efforts.

Taken together, these regional characteristics indicate that a single global distribution or product strategy will rarely suffice. Instead, successful market engagement depends on tailoring regulatory dossiers, technical support, and logistics models to regional realities, while fostering partnerships with local distributors, laboratories, and government stakeholders to enable rapid, reliable adoption.

In-depth corporate and institutional appraisal identifying how manufacturers, distributors, and collaborative partnerships create competitive differentiation through validation, supply continuity and support services

Key corporate players and institutional actors in the ASFV antibody ELISA space are increasingly evaluated on their ability to deliver validated assay performance, reliable supply chains, and integrated support services. Established manufacturers that offer multiple ELISA formats demonstrate competitive advantage when they provide comprehensive technical dossiers, cross-validation data, and scalable manufacturing to accommodate urgent surveillance needs. At the same time, emerging innovators contribute specialized assay chemistries, simplified user interfaces, or modular platforms that ease deployment in resource-limited settings and veterinary clinics. Distributors and logistics partners play a pivotal role by ensuring cold-chain integrity, timely delivery, and regulatory support across multiple jurisdictions, thereby enabling manufacturers to reach decentralized testing sites.

Institutional collaborations between commercial firms and research institutions or government agencies have increased, and these partnerships frequently yield shared reference standards, co-developed validation protocols, and training programs that accelerate market entry. As procurement officers place higher value on end-to-end solutions, companies that bundle assays with validation services, digital data integration, and on-the-ground technical assistance achieve higher adoption rates. Ultimately, competitive differentiation now rests on a combination of technical excellence, demonstrable regulatory compliance, and the ability to sustain uninterrupted supply in varied regional contexts.

Actionable strategic recommendations for manufacturers, distributors and stakeholders to accelerate adoption of antibody ELISA assays while strengthening validation, supply resilience and support services

Industry leaders should pursue a multi-pronged strategy to enhance adoption of ASFV antibody ELISA diagnostics while strengthening operational resilience. First, invest in robust validation and documentation that align assay performance with regulatory expectations and laboratory accreditation standards, thereby lowering barriers for procurement across public and private diagnostic laboratories. Second, diversify distribution footprints by combining direct sales in core markets with strategic partnerships with national and international distributors to reduce tariff exposure and improve lead times. Third, expand support services to include on-site or remote training, integration with laboratory information systems, and post-market surveillance of assay performance to build trust with government agencies and research institutions.

Furthermore, align product development with application-specific requirements by offering assay variants optimized for disease diagnosis, surveillance, research, and vaccine development, and ensure that surveillance-focused solutions address both active and passive surveillance workflows. Emphasize modularity and usability so veterinary hospitals and smaller clinics can implement assays with minimal infrastructure. Finally, fortify supply chain resilience through regional warehousing, alternate sourcing strategies for key reagents, and transparent contractual terms that clarify continuity commitments. By executing these priorities, industry leaders will not only improve market access but also support more effective and sustainable disease control programs.

Transparent mixed-methods research methodology detailing primary interviews, secondary validation and analytical frameworks used to derive practical insights on ELISA diagnostics adoption and deployment

This report synthesizes qualitative and primary research methodologies to ensure robust, defensible insights. Primary inputs derive from structured interviews with diagnostic laboratory directors, government surveillance managers, veterinary clinicians, and research scientists, supplemented by vendor briefings and distributor assessments to capture real-world procurement and logistical considerations. Secondary analysis integrates peer-reviewed literature, regulatory guidance documents, and technical validation reports to triangulate performance characteristics of Competitive, Indirect, and Sandwich ELISA formats.

Analytical approaches include comparative assay performance mapping, end-user requirement profiling, and distribution channel analysis, each designed to identify friction points in validation, adoption, and supply continuity. Where appropriate, case studies illustrate successful assay deployments, regulatory pathways, and distributor partnerships. Throughout the methodology, emphasis rests on reproducibility and transparency: interview protocols, inclusion criteria for public documents, and analytical assumptions are documented, and sensitivity checks ensure that qualitative conclusions remain consistent across stakeholder groups and regional contexts. This mixed-methods approach yields actionable findings grounded in empirical evidence and practitioner experience.

Concise concluding synthesis reinforcing the necessity for adaptive validation, supply chain resilience and collaborative deployment strategies to optimize ELISA-based ASFV antibody testing

In summary, antibody ELISA diagnostics for African Swine Fever Virus occupy a critical position within modern surveillance, diagnostic, and research ecosystems. The combination of advancing assay chemistries, shifting procurement dynamics, and region-specific regulatory realities demands that manufacturers, distributors, and end users adopt adaptive strategies that prioritize validation, supply continuity, and tailored support. Segmentation by test type, end user, application, and distribution channel clarifies where product differentiation and service enhancements will most effectively drive adoption, while regional nuance underscores the need for localized regulatory and logistics approaches. Moving from insight to implementation will require coordinated efforts among industry, government, and research institutions to ensure assays deliver reliable results within the operational constraints of diverse laboratory and field environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Product Type

  • 8.1. Indirect ELISA Kits
    • 8.1.1. IgG Antibody Detection
    • 8.1.2. Total Antibody Detection
  • 8.2. Blocking And Competitive ELISA Kits
    • 8.2.1. Monoclonal Antibody-Based
    • 8.2.2. Polyclonal Antibody-Based
  • 8.3. Double-Antigen Sandwich ELISA Kits

9. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Test Type

  • 9.1. Competitive Elisa
  • 9.2. Indirect Elisa
  • 9.3. Sandwich Elisa

10. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Sample Type

  • 10.1. Serum Samples
    • 10.1.1. Individual Animal Serum
    • 10.1.2. Pooled Serum
  • 10.2. Plasma Samples
  • 10.3. Whole Blood
  • 10.4. Oral Fluid
  • 10.5. Tissue Extracts

11. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. International Distributors
    • 11.2.2. National Distributors
  • 11.3. Online

12. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Application

  • 12.1. Disease Diagnosis
  • 12.2. Research
  • 12.3. Surveillance
    • 12.3.1. Active Surveillance
    • 12.3.2. Passive Surveillance
  • 12.4. Vaccine Development

13. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by End User

  • 13.1. Diagnostic Laboratories
    • 13.1.1. Private
    • 13.1.2. Public
  • 13.2. Government Agencies
  • 13.3. Research Institutions
  • 13.4. Veterinary Hospitals

14. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States ELISA Kit for Antibody Detection Against African Swine Fever Virus Market

18. China ELISA Kit for Antibody Detection Against African Swine Fever Virus Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abcam plc
  • 19.6. Adiagen, Inc.
  • 19.7. Bionote, Inc.
  • 19.8. Biosellal S.A.
  • 19.9. BioStone Animal Health LLC
  • 19.10. Boehringer Ingelheim Svanova
  • 19.11. Cusabio Biotech Co., Ltd.
  • 19.12. Gold Standard Diagnostics, Inc.
  • 19.13. ID.vet Innovative Diagnostics
  • 19.14. IDEXX Laboratories, Inc.
  • 19.15. Indical Bioscience GmbH
  • 19.16. J&G Biotech Ltd.
  • 19.17. Merck KGaA
  • 19.18. R&D Systems, Inc.
  • 19.19. Tetracore, Inc.
  • 19.20. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY IGG ANTIBODY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY IGG ANTIBODY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY IGG ANTIBODY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TOTAL ANTIBODY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TOTAL ANTIBODY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TOTAL ANTIBODY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY MONOCLONAL ANTIBODY-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY MONOCLONAL ANTIBODY-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY MONOCLONAL ANTIBODY-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POLYCLONAL ANTIBODY-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POLYCLONAL ANTIBODY-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POLYCLONAL ANTIBODY-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DOUBLE-ANTIGEN SANDWICH ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DOUBLE-ANTIGEN SANDWICH ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DOUBLE-ANTIGEN SANDWICH ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COMPETITIVE ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COMPETITIVE ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SANDWICH ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SANDWICH ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIVIDUAL ANIMAL SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIVIDUAL ANIMAL SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIVIDUAL ANIMAL SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POOLED SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POOLED SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POOLED SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PLASMA SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PLASMA SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PLASMA SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ORAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ORAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TISSUE EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TISSUE EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TISSUE EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ACTIVE SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ACTIVE SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ACTIVE SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PASSIVE SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PASSIVE SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PASSIVE SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, B